A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...

World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.

On Dec. 2, 2020, the international journal Nature splashed the cover with a retinal image and the bold headline "Turning back time." A title more fitting for a movie or novel referred to a research ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of age-related optic nerve damage.

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Adult cells in our body can only give rise to the same cell type. For example, a skin cell cannot give rise to a muscle cell but to skin cells only. This limits the potential use of adult cells for ...

Reprogramming often yields heterogeneous cell fates, yet the underlying mechanisms remain poorly understood. To address this, we developed single-cell transcription factor sequencing (scTF-seq), a ...